𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Morphine radioimmunoassay specificity before and after extraction of plasma and cerebrospinal fluid

✍ Scribed by Patricia Y. Grabinski; Robert F. Kaiko; T. D. Walsh; Kathleen M. Foley; Raymond W. Houde


Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
571 KB
Volume
72
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Impact of quinidine on plasma and cerebr
✍ S. H. Sindrup; K. BrΓΈsen; F. Nielsen; U. Hofmann; G. Mikus; J. Asmussen; S. H. I πŸ“‚ Article πŸ“… 1996 πŸ› Springer 🌐 English βš– 609 KB

Objective: The analgesic effect of codeine depends on its O-demethylation to morphine via sparteine oxygenase (CYP2D6) in the liver and presumably also via this enzyme in the CNS. We studied the ability of quinidine, which is a potent inhibitor of CYP2D6, to penetrate the blood brain barrier and its

Pharmacokinetics of vinpocetine and its
✍ Margarita PolgΓ‘r; LΓ‘szlΓ³ Vereczkey; IstvΓ‘n NyΓ‘ry πŸ“‚ Article πŸ“… 1985 πŸ› Elsevier Science 🌐 English βš– 641 KB

The pharmacokinetics of vinpocetine (ethyl apovincaminate, Cavinton) and its metabolite, apovincaminic acid, was studied in patients with cerebrovascular disorders. Vinpocetine (1 mg/kg) was infused intravenously over 25 min. The elimination half-life of the parent drug in plasma was 4.7k2.13 h. Tot

Pharmacokinetic behavior of huperzine A
✍ Qiao Wang; Guoshen Chen πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 87 KB πŸ‘ 3 views

## Abstract The aim of this study was to investigate the pharmacokinetic behavior of huperzine A (Hup A) in plasma and cerebrospinal fluid (CSF) after intranasal administration (0.5 mg/kg) in male Sprague‐Dawley rats. A pharmacokinetic study of intravenous Hup A (0.5 mg/kg) was also performed. The

Pharmacokinetic modeling of plasma and c
✍ E. Chatelut; H. Roche; Y. Plusquellec; F. Peyrille; J. De Biasi; A. Pujol; P. Ca πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 436 KB

A pharmacokinetic study was performed in plasma and cerebrospinal fluid (CSF) of patients suffering from brain tumors to describe the disposition of methotrexate. An open three-compartment model was developed to fit together the data obtained in plasma and CSF. The pharmacokinetic parameters obtaine